Full text
Earnings transcript
Read the complete earnings call transcript.
INVX
Innovex International, Inc.
$27.31
-0.21
(-0.76%)
| Exchange: | NYSE |
| Market Cap: | 1.907B |
| Shares Outstanding: | 34.59M |
Delayed data
About The Company
| Sector: | EnergyView sector performance | |||||
| Industry: | Oil & Gas Equipment & ServicesView industry performance | |||||
| CEO: | Adam Anderson | |||||
| Full Time Employees: | 2160 | |||||
| Address: |
| |||||
| Website: | https://www.innovex-inc.com |
Innovex International, Inc. designs, manufactures, sells, and rents mission critical engineered products to the oil and natural gas industry worldwide. It provides drilling enhancement tools to optimize drilling performance, increase rate of penetration, and mitigate downhole challenges; and fishing and intervention which supports workover, intervention, drilling and completion activities, as well as manufactures and sells products including external catch tools, internal catch tools, and other related fishing and remedial tools. The company also offers well production solutions comprising products and services that enable artificial lift in wells and provides artificial lift accessory products and services, as well as wellhead penetrators, tubing hangers and adapters, ESP cable management, and spooling services; service, mileage, and others; subsea equipment and engineered systems for offshore applications, including subsea wellheads, subsea connectors, casing connectors, deepwater centralization solutions, and diverter systems; and surface wellhead systems. In addition, it provides well completion portfolio comprising products used to enable a well to be stimulated and put on production, such as liner hanger systems, toe initiation products, frac plugs, completion packers, casing flotation products, and related completion accessories; and well construction portfolio that consists of products designed to ensure the structural integrity of the wellbore. Further, the company offers products utilized to support effective cement placement between the wellbore and casing. It sells and rents its products to international and national oil companies, independent exploration and production companies, and multinational service companies. Its products have applications in the onshore and offshore oil and natural gas wells, including well construction, well completion, and well production and intervention. The company was founded in 2016 and is headquartered in Humble, Texas.
Click to read more…
Revenue Segmentation
INVX full analysis
Welcome to MARKETSNAP’s SWOT analysis for Innovex, also known by its ticker INVX. If you’re a long-term investor looking to build wealth and grow your portfolio, you’re in the right place. Today, we’re diving deep into Innovex, a player in its industry that’s been making some serious waves lately. Let’s break down what makes this company tick, analyze its recent performance, and unpack a detailed SWOT analysis to see if it’s a worthy addition to your long-term strategy. Stick with…
Industry Peers
| TICKER | COMPANY | MKT CAP | P/E | FWD P/E | ROIC |
|---|---|---|---|---|---|
| INVX | Innovex International, Inc. | 1.9B | 32.0 | 17.1 | 6.1% |
 XPRO | Expro Group Holdings N.V. | 1.8B | 89.9 | 19.0 | 1.6% |
 FLOC | Flowco Holdings Inc. | 1.7B | 11.9 | 12.5 | 8.5% |
 WTTR | Select Water Solutions, Inc. | 2.2B | 73.2 | 30.7 | 3.6% |
 AESI | Atlas Energy Solutions Inc. | 1.5B | — | — | -3.0% |
 EROK | EagleRock Land LLC | 2.3B | — | 11.0 | -2.7% |
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 555,539 | 660,803 | 978,251 |
| Gross Profit | 195,437 | 232,631 | 242,538 |
| EBITDA | 129,931 | 184,766 | 191,853 |
| Operating Income | 97,282 | 49,075 | 113,745 |
| Net Income | 73,926 | 140,325 | 83,298 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 1,028,181 | 1,197,483 | 1,268,307 |
| Total Liabilities | 146,379 | 239,327 | 210,608 |
| Total Stockholders Equity | 328,921 | 958,156 | 1,057,699 |
| Total Debt | 84,907 | 91,068 | 79,287 |
| Cash and Cash Equivalents | 7,406 | 73,278 | 203,407 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 75,864 | 93,439 | 190,912 |
| Capital Expenditure | -15,487 | -13,594 | -35,132 |
| Free Cash Flow | -24,899 | 79,845 | 155,780 |
| Net Income | 604 | 140,325 | 83,298 |
| Net Change in Cash | -1,010 | 65,872 | 0 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 1,308,809.586 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 1,390,064.772 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 1,350,000 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 287,618.680 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 307,428.094 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 297,660.374 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 194,557.970 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 210,410.235 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 202,593.725 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 197,299.701 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 209,548.712 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 203,509.050 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 2.920 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 3.030 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 2.800 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 2 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Revenue Growth: Innovex reported Q1 2025 revenue of $240 million, reflecting an 88% year-over-year increase as highlighted in the earnings call transcript. This significant growth underscores the company’s ability to scale operations and capture market share.
- Operational Efficiency: The earnings call emphasized a capital-light model, which allows Innovex to maintain flexibility and navigate market fluctuations effectively, contributing to strong gross profit margins as inferred from key financial metrics.
- Positive Earnings Performance: Key financial results from the Q1 2025 earnings call indicate that Innovex exceeded revenue and EPS expectations, signaling strong operational performance and investor confidence.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates INVX intrinsic value between $13.99 – $23.21 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about INVX valuation
Is Innovex International, Inc. (INVX) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Innovex International, Inc. (INVX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is INVX a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether INVX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is INVX’s P/E ratio?
You can see INVX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for INVX?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is INVX a good long-term investment?
Whether INVX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
INVX
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-0.76
Trading Metrics:
| Open: | 27.39 | Previous Close: | 27.52 | |
| Day Low: | 27.23 | Day High: | 28.12 | |
| Year Low: | 11.93 | Year High: | 33.71 | |
| Price Avg 50: | 29.03 | Price Avg 200: | 26.55 | |
| Volume: | 1.013M | Average Volume: | 618615 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
